Literature DB >> 12412934

Causes of elevated troponin I with a normal coronary angiogram.

T K Bakshi1, M K F Choo, C C Edwards, A G Scott, H H Hart, G P Armstrong.   

Abstract

BACKGROUND: The new definition of myocardial infarction (MI) emphasizes the pre-eminent role of troponin for diagnosis. Troponin rise indicates myocardial injury, but is not synonymous with infarction or ischaemia. AIMS: To review the precipitating event for troponin elevation in patients with angiographically normal coronary arteries, in a district general hospital.
METHODS: Consecutive patients with elevated troponin I (TnI) who underwent angiography for suspected coronary disease were included in the present study if they had normal or mild disease (<50% diameter loss without complex features or thrombus). Precipitating event for TnI elevation was assigned on the totality of clinical evidence.
RESULTS: Twenty-one patients qualified, with an average age of 50 years (range 33-73). Sixty-two per cent of participants were female. Troponin release was attributed to tachycardia in six patients, only two of whom had haemodynamic compromise. Physical exertion was the precipitating factor in two patients; pericarditis in two patients; and severe congestive heart failure in one patient. Ten of 21 patients had no identifiable cause for a rise in TnI concentration. Five of 21 patients had left-ventricular wall motion abnormalities. There were no deaths or MI at 41 +/- 24 weeks follow up.
CONCLUSION: Troponin is a sensitive marker of myocardial injury and may rise following apparently minor insults. A rise in TnI concentration may have a cause other than acute coronary syndrome and may occur without significant angiographic coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12412934     DOI: 10.1046/j.1445-5994.2002.00270.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  29 in total

Review 1.  Troponin I in the intensive care unit setting: from the heart to the heart.

Authors:  Chiara Lazzeri; Manuela Bonizzoli; Giovanni Cianchi; Gian Franco Gensini; Adriano Peris
Journal:  Intern Emerg Med       Date:  2008-03-07       Impact factor: 3.397

2.  Cardiac magnetic resonance imaging for the diagnosis of patients presenting with chest pain, raised troponin, and unobstructed coronary arteries.

Authors:  Edouard Gerbaud; Emmanuel Harcaut; Pierre Coste; Matthew Erickson; Mathieu Lederlin; Jean Noel Labèque; Jean Marie Perron; Hubert Cochet; Pierre Dos Santos; Catherine Durrieu-Jaïs; François Laurent; Michel Montaudon
Journal:  Int J Cardiovasc Imaging       Date:  2011-05-03       Impact factor: 2.357

3.  Characterization of Cardiac Troponin Elevation in the Setting of Pediatric Supraventricular Tachycardia.

Authors:  Jeremy P Moore; Lisa Arcilla; Shuo Wang; Michael S Lee; Kevin M Shannon
Journal:  Pediatr Cardiol       Date:  2015-10-19       Impact factor: 1.655

4.  Predictors of High-Sensitivity Cardiac Troponin T Elevation in Patients with Acute Paroxysmal Supraventricular Tachycardia and Ischemic Heart Disease.

Authors:  Mehdi Sayadnik; Akbar Shafiee; Yaser Jenab; Arash Jalali; Saeed Sadeghian
Journal:  Tex Heart Inst J       Date:  2017-10-01

5.  Do induced tachycardias within the scope of electrophysiological studies lead to elevated plasma troponin I levels?

Authors:  D Bandorski; H Bogossian; B Lemke; R Höltgen; M Wieczorek; M Brück
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-12

6.  Disease distribution and outcome in troponin-positive patients with or without revascularization in a chest pain unit: results of the German CPU-Registry.

Authors:  Alexander Illmann; Thomas Riemer; Raimund Erbel; Evangelos Giannitsis; Christian Hamm; Michael Haude; Gerd Heusch; Lars S Maier; Thomas Münzel; Claus Schmitt; Burghard Schumacher; Jochen Senges; Thomas Voigtländer; Harald Mudra
Journal:  Clin Res Cardiol       Date:  2014-01       Impact factor: 5.460

7.  Beneficial effects of edaravone in experimental model of amitriptyline-induced cardiotoxicity in rats.

Authors:  Nursah Basol; Hatice Aygun; Serdar Savas Gul
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-07-04       Impact factor: 3.000

8.  Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitus.

Authors:  Jonas Hallén; Odd Erik Johansen; Kåre I Birkeland; Lars Gullestad; Svend Aakhus; Knut Endresen; Solve Tjora; Allan S Jaffe; Dan Atar
Journal:  Cardiovasc Diabetol       Date:  2010-09-15       Impact factor: 9.951

9.  The clinical significance of cardiac troponins in medical practice.

Authors:  Mohammed A Al-Otaiby; Hussein S Al-Amri; Abdulrahman M Al-Moghairi
Journal:  J Saudi Heart Assoc       Date:  2010-10-20

10.  Determinants of cardiac troponin T elevation in COPD exacerbation - a cross-sectional study.

Authors:  Pål H Brekke; Torbjørn Omland; Stein Harald Holmedal; Pål Smith; Vidar Søyseth
Journal:  BMC Pulm Med       Date:  2009-07-19       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.